XNYS
NVST
Market cap3.35bUSD
Jul 17, Last price
19.75USD
1D
0.15%
1Q
30.11%
IPO
-29.46%
Name
Envista Holdings Corp
Chart & Performance
Profile
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
Income | |||||||||
Revenues | 2,510,600 -2.18% | 2,566,500 -0.10% | 2,569,100 2.40% | ||||||
Cost of revenue | 1,237,000 | 1,209,800 | 1,194,400 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 1,273,600 | 1,356,700 | 1,374,700 | ||||||
NOPBT Margin | 50.73% | 52.86% | 53.51% | ||||||
Operating Taxes | 33,900 | 45,300 | 45,900 | ||||||
Tax Rate | 2.66% | 3.34% | 3.34% | ||||||
NOPAT | 1,239,700 | 1,311,400 | 1,328,800 | ||||||
Net income | (1,118,600) 1,016.37% | (100,200) -141.22% | 243,100 -7.74% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (7,900) | 12,700 | |||||||
BB yield | 0.20% | -0.21% | |||||||
Debt | |||||||||
Debt current | 150,500 | 175,900 | 537,000 | ||||||
Long-term debt | 1,550,600 | 1,648,200 | 1,140,500 | ||||||
Deferred revenue | 8,400 | 8,600 | |||||||
Other long-term liabilities | 139,800 | 134,000 | 7,100 | ||||||
Net debt | 632,000 | 884,100 | 1,231,100 | ||||||
Cash flow | |||||||||
Cash from operating activities | 336,500 | 275,700 | 182,700 | ||||||
CAPEX | (33,800) | (58,200) | (75,700) | ||||||
Cash from investing activities | (54,600) | (62,400) | (657,300) | ||||||
Cash from financing activities | (103,700) | 118,900 | 12,500 | ||||||
FCF | 1,444,000 | 1,181,400 | 1,177,600 | ||||||
Balance | |||||||||
Cash | 1,069,100 | 940,000 | 606,900 | ||||||
Long term investments | (160,500) | ||||||||
Excess cash | 943,570 | 811,675 | 317,945 | ||||||
Stockholders' equity | (856,800) | 415,700 | 507,900 | ||||||
Invested Capital | 5,479,100 | 5,584,500 | 5,391,655 | ||||||
ROIC | 22.41% | 23.90% | 24.50% | ||||||
ROCE | 27.55% | 22.61% | 23.52% | ||||||
EV | |||||||||
Common stock shares outstanding | 172,200 | 166,900 | 177,600 | ||||||
Price | 19.29 -19.83% | 24.06 -28.54% | 33.67 -25.28% | ||||||
Market cap | 3,321,738 -17.28% | 4,015,614 -32.85% | 5,979,792 -25.28% | ||||||
EV | 3,953,738 | 4,899,714 | 7,210,892 | ||||||
EBITDA | 1,314,400 | 1,519,300 | 1,536,800 | ||||||
EV/EBITDA | 3.01 | 3.22 | 4.69 | ||||||
Interest | 46,400 | 63,400 | 38,400 | ||||||
Interest/NOPBT | 3.64% | 4.67% | 2.79% |